Congestive heart failure · people with confirmed diagnosis of Marfan syndrome
Beta‐blockers showed no clear difference in congestive heart failure compared with placebo, no treatment or surveillance only (low certainty).
1 finding from 1 review
Cardiovascular surgery · people with confirmed diagnosis of Marfan syndrome
Beta‐blockers showed no clear difference in cardiovascular surgery compared with placebo, no treatment or surveillance only (low certainty).
1 finding from 1 review
Aortic root diameter > 6 cm · people with confirmed diagnosis of Marfan syndrome
Beta‐blockers showed no clear difference in aortic root diameter > 6 cm compared with placebo, no treatment or surveillance only (low certainty).
1 finding from 1 review
Improvement in vertigo · people with vestibular migraine
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in vertigo frequency · people with vestibular migraine
1 finding from 1 review
Serious adverse events · people with vestibular migraine
It is very uncertain whether beta‐blockers changes serious adverse events compared with placebo (very low certainty).
1 finding from 1 review
Leaving the study early · patients with schizophrenia
Beta‐blockers showed no clear difference in global state: 1. Leaving the study early ‐ Short term compared with placebo (low certainty).
1 finding from 1 review
Relapse · patients with schizophrenia
Beta‐blockers showed no clear difference in global state: 2. Relapse ‐ short term compared with placebo (low certainty).
1 finding from 1 review
Adverse effects: 1. Death ‐ short term · patients with schizophrenia
1 finding from 1 review
Adverse effects: 1. Death ‐ medium term · patients with schizophrenia
1 finding from 1 review
Adverse effect: 2. General ‐ Short term · patients with schizophrenia
Beta‐blockers showed no clear difference in adverse effect: 2. General ‐ Short term compared with placebo (low certainty).
1 finding from 1 review
Adverse effects: 3. Specific ‐ cardiovascular ‐ short term · patients with schizophrenia
Beta‐blockers showed no clear difference in adverse effects: 3. Specific ‐ cardiovascular ‐ short term compared with placebo (low certainty).
1 finding from 1 review
SBP (mmHg) · adults with primary hypertension
1 finding from 1 review
Diastolic blood pressure · adults with primary hypertension
1 finding from 1 review
Heart rate · adults with primary hypertension
1 finding from 1 review
Pulse pressure · adults with primary hypertension
1 finding from 1 review
Withdrawals due to adverse events · adults with primary hypertension
1 finding from 1 review
Early all‐cause mortality (within 30 days) · adults undergoing non‐cardiac surgery under general anaesthesia (to include: low‐risk, medium‐risk, and high‐risk surgeries)
Perioperative beta‐blockers showed no clear difference in early all‐cause mortality (within 30 days) compared with placebo or standard care (low certainty).
1 finding from 1 review
Myocardial infarction (0 to 30 days) · adults undergoing non‐cardiac surgery under general anaesthesia (to include: low‐risk, medium‐risk, and high‐risk surgeries)
Perioperative beta‐blockers may leads to lower acute myocardial infarction (within 30 days) compared with placebo or standard care (low certainty).
1 finding from 1 review
Cerebrovascular events (within 30 days) · adults undergoing non‐cardiac surgery under general anaesthesia (to include: low‐risk, medium‐risk, and high‐risk surgeries)
Perioperative beta‐blockers showed no clear difference in cerebrovascular events (within 30 days) compared with placebo or standard care (low certainty).
1 finding from 1 review